Sign in

CIK 0001650648

  • Non-accelerated filer
  • Smaller reporting company

4D Molecular Therapeutics, Inc.

Sign in to watch
Ticker
FDMT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473506994
Phone
+1 510-505-2680
Business address
5858 HORTON STREET #455, EMERYVILLE, CA, 94608
Former names
4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
  1. 4 Gift Chief Executive Officer gave 600,000 shares (gift)
  2. 4 Planned sale Chief Legal and HR Officer sold 3,750 shares at $20.00 ($75,000)
  3. 4 Planned sale Director sold 5,000 shares at $20.05 ($100,270)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market sale Chief Legal and HR Officer sold 2,248 shares at $19.30 ($43,386)
  6. 4 Open-market sale Chief Executive Officer sold 34,446 shares at an average $20.61 ($709,873)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale Chief Executive Officer sold 19,524 shares at an average $20.10 ($392,474)
  12. 4 Option exercise Chief Financial Officer acquired 3,000 shares (option exercise)
  13. 4 Open-market sale Chief Executive Officer sold 86,877 shares at an average $23.23 ($2,018,344)
  14. 4 Open-market sale Chief Legal and HR Officer sold 6,000 shares at an average $22.79 ($136,725)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 9 · 170 filings